Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • Diabetic foot...

    Diabetic foot amputations may be avoided with silver nanoparticles : Study

    Written by supriya kashyap kashyap Published On 2016-09-05T14:59:41+05:30  |  Updated On 5 Sept 2016 2:59 PM IST
    Diabetic foot amputations may be avoided with silver nanoparticles : Study

    One of the major complications of diabetes is the appearance of wounds in the lower extremities that do not heal properly. In this situation, a group of researchers from the UNAM created a solution made of silver nanoparticles, which in clinical trials has healed ulcers people with diabetic foot, avoiding the amputation of more than 90 percent of patients treated.


    "The ulcer is an open wound, susceptible to infection by bacteria and fungi that generate inflammation, which prevents injury to heal; however, in applying the silver nanoparticles an antibacterial effect that contributes to create healthy tissue”, said Dr. Karla Oyuky Juárez Moreno, researcher at the Center for Nanoscience and Nanotechnology (CNyN) located in Ensenada, Baja California.


    Result in three months


    The development called Nagsil Dermo® achieves in three months to heal diabetic foot ulcers. First a doctor should do heals, remove dead tissue and then placing the solution spray. Dr. Juarez Moreno stressed that for an effective treatment must be apply daily and be supervised by specialists.


    According to data from the Ministry of Health, seven out of ten cases of diabetic foot ulcers result in amputation and the World Health Organization (WHO) reports that due to the lack of control of blood glucose, between 40 and 85 percent of patients lose their limb.


    A commercial cosmetics tested


    The solution applied in patients that had a treatment with antibiotic during more than six months but don’t see improvements, some had the diagnostic of amputation. “With our development report us a cicatrization, the time depends of the ulcer.


    Exist four types wich reflect vascular damage and tissue. “Who have the levels one, two and three relieved in less of six months, therefore those wich have the level four where the amputation is inevitable, in this cases have us a ten per cent of success”, detailed Dr. Juarez Moreno.


    CNyN researchers led by Dr. Nina Bogdanchikova work with the International Network of Bionanotechnology the National Council of Science and Technology (CONACYT) and in collaboration with Dr. César Almonaci (graduated from the Faculty of Medicine, UNAM).


    The group of scientists has implemented innovation in private clinics and health sector, including ISSSTECALI hospitals and General de Rosarito, both located in Baja California, in the latter over a hundred cases were treated and 94 percent saved their limbs.


    At national level there are 60 patients who have saved their limbs from the use of Nagsil Dermo®, an economic cosmetic product whose price is 550 pesos for a bottle of 50 milliliters, which is marketed through Bionag, a spin off created by the Network Conacyt located in Tijuana.


    Scientific and technological development has international certificates toxicity committees supporting the safety of silver nanoparticles for use as a cosmetic in humans. They are also coated with a polymer that provides stability for more than two years.


    Currently is working to increase its average shelf life and is being patented. Also, the development of the UNAM, due to its antibacterial action, is also applicable to veterinary level for livestock diseases and cosmetic use as dermatitis.

    Center for Nanoscience and NanotechnologyDr Karla Oyuky Juárez MorenoDr Nina BogdanchikovaNagsil Dermonanoparticlessilver nanoparticlesWorld Health Organization

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok